RESEARCHERS from the Fiona Elsey Cancer Research Institute have released findings into a study on the use of personalised treatment for renal cancer patients.<\/p>\n
Titled Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma, the paper was developed by institute director Professor George Kannourakis, PhD candidate Revati Sharma, Dr Prashanth Pritviraj and Professor Nuzhat Ahmed.<\/p>\n
Ms Sharma said the study highlights the possibilities of direct and individualised care for renal cancer patients.<\/p>\n
\u201cPrecision medicine offers more specific and individualised treatments for patients and this work shows the importance of precision medicine in the treatment of renal cell carcinoma patients,\u201d she said.<\/p>\n
With renal cancer initially spreading from the kidneys, the research highlights the use of individualised medical practices informed by a person\u2019s characteristics, genetic makeup and lifestyle habits.<\/p>\n
Over 3000 Australians are diagnosed with renal cancer each year, with the illness being the ninth most common cancer diagnosis for men.<\/p>\n
Professor Kannourakis said the study showcased the work going on at FECRI.<\/p>\n
\u201cThis publication is a great example of the relevant and ground-breaking work that the team here at the institute are doing into the immunology of cancer,\u201d he said.<\/p>\n
\u201cOur program is building great momentum and will continue to produce outcomes.\u201d<\/p>\n
Five PhD students and 15 staff members make up FECRI\u2019s research team, which is an independently funded institute.<\/p>\n
The renal cancer work was supported through FECRI\u2019s John Turner Cancer Research Fund and the Hudson Institute of Medical Research via the State Government\u2019s Operational Infrastructure Support program.<\/p>\n","protected":false},"excerpt":{"rendered":"
RESEARCHERS from the Fiona Elsey Cancer Research Institute have released findings into a study on the use of personalised treatment for renal cancer patients. Titled Precision Medicine: An Optimal Approach to Patient Care in Renal Cell Carcinoma, the paper was developed by institute director Professor George Kannourakis, PhD candidate Revati Sharma, Dr Prashanth Pritviraj and […]<\/p>\n